Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

BioCorRx Inc. (BICX)

0.2870
0.0000
(0.00%)
As of April 29 at 4:00:00 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Lourdes Felix CEO, CFO & Director 259.85k -- 1968
Mr. Louis Charles Lucido President & Director 60k -- 1948
Dr. George N. Fallieras Medical Consultant -- -- --

BioCorRx Inc.

2390 East Orangewood Avenue
Suite 570
Anaheim, CA 92806
United States
714 462 4880 https://www.biocorrx.com
Sector: 
Healthcare

Description

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid addiction and alcoholism. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Corporate Governance

BioCorRx Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 12:30 PM UTC - May 19, 2025 at 12:30 PM UTC

BioCorRx Inc. Earnings Date

Recent Events

March 31, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 1, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 15, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters